top of page
Suche

Clin Cancer Res. 2022 Nov

  • christineeulenburg
  • 19. Nov. 2023
  • 1 Min. Lesezeit

Gluz O, Nitz U, Kolberg-Liedtke C, Prat A, Christgen M, Kuemmel S, Mohammadian MP, Gebauer D, Kates R, Paré L, Grischke EM, Forstbauer H, Braun M, Warm M, Hackmann J, Uleer C, Aktas B, Schumacher C, Wuerstlein R, Graeser M, Pelz E, Jóźwiak K, Zu Eulenburg C, Kreipe HH, Harbeck N; ADAPT TN investigators.Clin Cancer Res. 2022 Nov 14;28(22):4995-

5003. doi: 10.1158/1078-0432.CCR-22-0482.

 
 
 

Aktuelle Beiträge

Alle ansehen
JAMA. 2023 Oct

Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis. Sánchez-de-la-Torre M, Gracia-Lavedan E,...

 
 
 
JAMA Oncol. 2023 Jul

Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone...

 
 
 
J Clin Oncol. 2023 Aug

De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+...

 
 
 

Comments

bottom of page